95
Participants
Start Date
April 30, 2007
Primary Completion Date
May 31, 2010
Study Completion Date
May 31, 2010
gemcitabine hydrochloride
1000 mg/m2 as 30 min i.v. infusion once weekly for 7/8 weeks and then every 3/4 weeks
Serine Proteinase Inhibitor WX-671
oral, daily
Serine Proteinase Inhibitor WX-671
oral, daily
Szent Laszlo Korhaz, Budapest
Cherkassy Regional Oncology Center, Cherkassy
Hospital Virgen de las Nieves, Granada
Centro Oncologico M.D. Anderson International Espana, Madrid
Centro di Riferimento Oncologico - Aviano, Aviano
Ukrainian Medical Stomatological Academy, Poltava
Dnipropetrovsk State Medical Academy, Dnipropetrovsk
Presidio Ospedaliero di Livorno, Livorno
Bukovinian State Medical University, Chernivtsy
Grigoriev Institute for Radiology Academy of Medical Science of Ukraine, Kharkiv
Otto-Meyerhof-Zentrum Tagesklinik, Heidelberg
Ivano-Frankovsk Regional Oncology Center, Ivano-Frankivsk
Azienda Ospedaliera di Rilievo Nazionale A.Cardarelli, Naples
Istituto Tumori/Fondazione Pascale, Naples
Donetsk Regional Antitumor Center, Donetsk
Moscow Oncology Hospital, Moscow
Russian Academy of Medical Sciences Cancer Research Center, Moscow
Central Clinical Hospital of the President of the Russian Federation, Moscow
Pavlov State Medical University, Saint Petersburg
Saint Petersburg State Medical University, Saint Petersburg
Rostov Research Institute of Oncology - Omsk, Omsk
Altai Oncology Center, Barnaul
Charite University Hospital - Campus Virchow Klinikum, Berlin
Universitaetsklinikum Freiburg, Freiburg im Breisgau
Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg
Johannes Gutenberg University, Mainz
III Medizinische Klinik Mannheim, Mannheim
Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich
Klinikum Rechts Der Isar - Technische Universitaet Muenchen, Munich
Hospital Muenchen Bogenhausen, Munich
Debreceni Egyetem Onkologiai Tanzek, Debrecen
Petz Aladar County Hospital, Gydr
University of Pecs Faculty of Medicine, Pécs
Szeged University, Szeged
Ospedale San Filippo Neri, Rome
Hospital de la Santa Cruz i Sant Pau, Barcelona
Vall d'Hebron University Hospital, Barcelona
Hospital Universitario de Elche, Elche
Institute of Oncology, Kiev
Lead Sponsor
Heidelberg Pharma AG
INDUSTRY